SIR 2019 Annual Scientific Meeting

Minimally Invasive Uterine Fibroid Embolization Reduces Bleeding Risk and Preserves Uterus

MedicalResearch.com Interview with:
Dr. Jemianne Bautista-Jia,  MD
Radiology resident
Kaiser Permanente

MedicalResearch.com: What is the background for this study?

Response: There were a few patient experiences that took me by surprise. I had a patient come to clinic for an initial consultation for uterine fibroid embolization (UFE) and I asked her how she knew about the procedure. She told me that she heard about it on the radio. Another patient who came in told me she heard about it from a close friend. Why did these patients not hear about UFE from their primary physicians?

Being a woman, I know that if I had this condition I would prefer a minimally invasive option over surgery. Surgery comes with complications, and I definitely would not want an organ removed from my body if I could avoid it. Therefore I wanted to study UAE to hopefully provide additional objective data to the scientific community to support its use for the treatment of women with fibroids.

MedicalResearch.com: How does this procedure differ from surgery treatments for UFE? 

Response: This procedure is minimally invasive. A small incision is made in the groin and the procedure is performed through the blood vessels. No tissue within the body is cut. The uterus is preserved, whereas in hysterectomy the entire uterus is removed from the body. 

MedicalResearch.com: What are the main findings?

Response: Uterine fibroid embolization resulted in lower rates of post-procedure blood transfusions, 0.9% versus 2.9% in patients who received myomectomy. In addition, UAE resulted in higher rates of improvement in menorrhagia or heavy menstrual bleeding, 75% versus 50% in the myomectomy cohort.

MedicalResearch.com: What should readers take away from your report?

 Response: Uterine fibroid embolization is more effective in treating menorrhagia as patients’ primary complaint, results in lower rates of complications, such as post-procedural blood transfusions. This treatment should be considered in all women with symptomatic uterine fibroids. 

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: Further research needs to be performed looking at Uterine fibroid embolization in patients who plan to become pregnant in the future and how the procedure impacts their fertility. 

MedicalResearch.com: Is there anything else you would like to add?

Response: I simply would like to thank everyone who helped with this study and thank you for your time.

No disclosures

Citation:

Outcomes of abdominal myomectomy vs uterine fibroid embolization in morbidly obese women Reddy, S et al.

Journal of Vascular and Interventional Radiology , Volume 28 , Issue 2 , S46 

[wysija_form id=”3″]

[last-modified]

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

 

Last Updated on March 26, 2019 by Marie Benz MD FAAD